» Articles » PMID: 34477212

The Differential Expression of Perilipin-2 in Hepatoblastoma and Its Association with Prognosis

Overview
Date 2021 Sep 3
PMID 34477212
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Perilipin-2, a lipid droplet (LD) coating protein, has been found to be involved in cancer progression. However, its role in hepatoblastoma (HB) is undefined. We collected 87 HB samples and the corresponding clinical data. Immunohistochemistry (IHC) staining was performed to detect perilipin-2 and the association of the perilipin-2 expression with clinical characteristics and prognosis was analyzed. The expression of perilipin-2 was increased in fetal HB components in comparison to embryonal HB components. The predominant staining pattern was vesicular in fetal HB cells, while it was granular in embryonal HB cells. Furthermore, strong expression of perilipin-2 was associated with the histopathological type of fetal predominant HB. Although event-free survival (EFS) did not differ to a statistically significant extent between the strong and weak expression groups in a univariate survival analysis, a multivariate survival analysis revealed that EFS was significantly improved in the strong perilipin-2 expression group. In conclusion, perilipin-2 is differentially expressed in HB and the strong expression of perilipin-2 predicts a better prognosis.

Citing Articles

Effects of µ-Conotoxin GIIIB on the cellular activity of mouse skeletal musculoblast: combined transcriptome and proteome analysis.

Wu H, He P, Jia R Proteome Sci. 2023; 21(1):17.

PMID: 37828502 PMC: 10568904. DOI: 10.1186/s12953-023-00221-w.


The combination of the low immunohistochemical expression of peroxiredoxin 4 and perilipin 2 predicts longer survival in pancreatic ductal adenocarcinoma with peroxiredoxin 4 possibly playing a main role.

Han J, Itoh T, Shioya A, Sakurai M, Oyama T, Kumagai M Histol Histopathol. 2023; 38(12):1415-1427.

PMID: 37787446 DOI: 10.14670/HH-18-666.


Challenges in Pharmacological Intervention in Perilipins (PLINs) to Modulate Lipid Droplet Dynamics in Obesity and Cancer.

Bombarda-Rocha V, Silva D, Badr-Eddine A, Nogueira P, Goncalves J, Fresco P Cancers (Basel). 2023; 15(15).

PMID: 37568828 PMC: 10417315. DOI: 10.3390/cancers15154013.

References
1.
Brasaemle D . Thematic review series: adipocyte biology. The perilipin family of structural lipid droplet proteins: stabilization of lipid droplets and control of lipolysis. J Lipid Res. 2007; 48(12):2547-59. DOI: 10.1194/jlr.R700014-JLR200. View

2.
Cairo S, Armengol C, De Reynies A, Wei Y, Thomas E, Renard C . Hepatic stem-like phenotype and interplay of Wnt/beta-catenin and Myc signaling in aggressive childhood liver cancer. Cancer Cell. 2008; 14(6):471-84. DOI: 10.1016/j.ccr.2008.11.002. View

3.
Cao Q, Ruan H, Wang K, Song Z, Bao L, Xu T . Overexpression of PLIN2 is a prognostic marker and attenuates tumor progression in clear cell renal cell carcinoma. Int J Oncol. 2018; 53(1):137-147. PMC: 5958875. DOI: 10.3892/ijo.2018.4384. View

4.
Carr R, Ahima R . Pathophysiology of lipid droplet proteins in liver diseases. Exp Cell Res. 2015; 340(2):187-92. PMC: 4744586. DOI: 10.1016/j.yexcr.2015.10.021. View

5.
Cast A, Valanejad L, Wright M, Nguyen P, Gupta A, Zhu L . C/EBPα-dependent preneoplastic tumor foci are the origin of hepatocellular carcinoma and aggressive pediatric liver cancer. Hepatology. 2017; 67(5):1857-1871. PMC: 8221081. DOI: 10.1002/hep.29677. View